Heat Biologics, Inc. reported the appointment of William Ostrander as vice president of finance in a filing with the Securities and Exchange Commission Tuesday.

Ostrander was previously the executive director of finance at Liquidia Technologies, Inc. He will receive an annual base salary of $220,000 and is eligible to receive an annual bonus of up to 20 percent of his salary.

Ostrander’s appointment follows the resignation of Robert Jakobs who entered into a separation agreement with the company on Sept. 20.

Heat Biologics, Inc. is a biotechnology company focused on the field of cancer immunotherapy. Its shares were trading at 52 cents on Friday, down 1 cent.